Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantinos Stavropoulos

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Circulation|July 13, 2016
Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation"Konstantinos Imprialos, Chrysoula Boutari, Konstantinos Stavropoulos
The New England Journal of Medicine|July 14, 2016
Testosterone Treatment in Older MenKonstantinos Stavropoulos, Chrysoula Boutari, Konstantinos Imprialos
Journal of Hypertension|March 30, 2017
Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?Michael Doumas, Konstantinos Stavropoulos, Konstantinos Imprialos
Heart Failure Clinics|September 2, 2019
Sodium-Glucose Cotransporter-2 Inhibitors, Reverse J-Curve Pattern, and Mortality in Heart FailureKonstantinos Imprialos, Konstantinos Stavropoulos, Vasilios Papademetriou
Vascular Health and Risk Management|November 6, 2019
Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitusGayatri Lessey, Konstantinos Stavropoulos, Vasilios Papademetriou
European Journal of Internal Medicine|September 5, 2024
A man with large periumbilical massesDimitrios Patoulias, Konstantinos Stavropoulos, Theocharis Koufakis
The New England Journal of Medicine|December 22, 2017
Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 DiabetesKonstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas
The New England Journal of Medicine|March 9, 2018
Effects of Sotagliflozin Added to Insulin in Type 1 DiabetesMichael Doumas, Konstantinos P Imprialos, Konstantinos Stavropoulos
Journal of Clinical Hypertension (Greenwich, Conn.)|July 20, 2017
Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?Konstantinos Stavropoulos, Konstantinos P Imprialos, Michael Doumas
Journal of Clinical Hypertension (Greenwich, Conn.)|December 14, 2017
Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertensionKonstantinos Stavropoulos, Konstantinos P Imprialos, Michael Doumas
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Circulation|July 13, 2016
Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation"Konstantinos Imprialos, Chrysoula Boutari, Konstantinos Stavropoulos
The New England Journal of Medicine|July 14, 2016
Testosterone Treatment in Older MenKonstantinos Stavropoulos, Chrysoula Boutari, Konstantinos Imprialos
Journal of Hypertension|March 30, 2017
Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?Michael Doumas, Konstantinos Stavropoulos, Konstantinos Imprialos
Heart Failure Clinics|September 2, 2019
Sodium-Glucose Cotransporter-2 Inhibitors, Reverse J-Curve Pattern, and Mortality in Heart FailureKonstantinos Imprialos, Konstantinos Stavropoulos, Vasilios Papademetriou
Vascular Health and Risk Management|November 6, 2019
Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitusGayatri Lessey, Konstantinos Stavropoulos, Vasilios Papademetriou
European Journal of Internal Medicine|September 5, 2024
A man with large periumbilical massesDimitrios Patoulias, Konstantinos Stavropoulos, Theocharis Koufakis
The New England Journal of Medicine|December 22, 2017
Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 DiabetesKonstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas
The New England Journal of Medicine|March 9, 2018
Effects of Sotagliflozin Added to Insulin in Type 1 DiabetesMichael Doumas, Konstantinos P Imprialos, Konstantinos Stavropoulos
Journal of Clinical Hypertension (Greenwich, Conn.)|July 20, 2017
Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?Konstantinos Stavropoulos, Konstantinos P Imprialos, Michael Doumas
Journal of Clinical Hypertension (Greenwich, Conn.)|December 14, 2017
Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertensionKonstantinos Stavropoulos, Konstantinos P Imprialos, Michael Doumas
Pageof 12